Integer Holdings Corp
Research Integer Holdings Corp (ITGR) on Bullrun: valuation model: 1.9% undervalued, market cap USD 4.26B, P/E 34.2. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerITGR
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Valuation signal1.9% undervalued
- Market capUSD 4.26B
- P/E34.2
- Financial periodQ2 2026
- RevenueUSD 439.58M
- Net incomeUSD 16.51M
- Free cash flowUSD 737.00K
- Gross margin24.9%
Valuation Snapshot
Bullrun's latest valuation model marks Integer Holdings Corp as 1.9% undervalued; latest market cap is USD 4.26B; P/E is 34.2.
Peer valuation comparison
Latest P/E is 34.18x versus a Healthcare sector median of 24.46x (39.8% above).
Latest P/E is 34.18x versus a United States median of 24.87x (37.5% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 1.85B | USD 102.81M | USD 105.12M | 27.0% | 2.89 | USD 17.16M | USD 1.19B | USD 1.75B |
| FY2024 | USD 1.72B | USD 119.90M | USD 99.85M | 26.7% | 3.36 | USD 46.54M | USD 990.15M | USD 1.62B |
| FY2023 | USD 1.56B | USD 90.65M | USD 60.28M | 26.3% | 2.69 | USD 23.67M | USD 959.93M | USD 1.52B |
| FY2022 | USD 1.33B | USD 66.38M | USD 41.65M | 26.0% | 1.99 | USD 24.27M | USD 925.26M | USD 1.42B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 4.26B | 34.2 | n/a | n/a |
| 2025 | 2025-12-31 | USD 2.69B | 27.3 | n/a | n/a |
| 2024 | 2024-12-31 | USD 4.45B | 39.4 | n/a | n/a |
| 2023 | 2023-12-29 | USD 3.30B | 40.9 | n/a | n/a |
| 2022 | 2022-12-30 | USD 2.27B | 33.4 | n/a | n/a |
| 2021 | 2021-12-31 | USD 2.83B | 30.6 | n/a | n/a |
About Integer Holdings Corp
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Integer Holdings Corp overvalued or undervalued?
Bullrun's valuation model currently marks Integer Holdings Corp as 1.9% undervalued.
What is Integer Holdings Corp's market cap?
Integer Holdings Corp's market capitalization is USD 4.26B.
What is Integer Holdings Corp's P/E ratio?
Integer Holdings Corp's price-to-earnings (P/E) ratio is 34.2.
What does Integer Holdings Corp do?
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.